Dr. Reddy’s Laboratories launches broad-spectrum antibiotics in United States
Dr. Reddy’s Laboratories Ltd. on Friday announced its launch of Doxycycline Capsules, 40 mg in the U.S. market. According to the company’s press statement, it is a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the …